Compounds > mitotane

mitotane and pasireotide

mitotane has been researched along with pasireotide in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (14.29)	29.6817
2010's	6 (85.71)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Leal-Cerro, A; León Justel, A; Mangas, MA; Soto Moreno, A; Webb, S	1
Biller, BM; Tritos, NA	1
Barahona Constanzo, MJ; del Pozo Picó, C	1
Feelders, RA; Hofland, LJ	1
Gadelha, MR; Vieira Neto, L	1
Aghi, MK; Lau, D; Rutledge, C	1
Biller, BMK; Tritos, NA	1

Reviews

7 review(s) available for mitotane and pasireotide

Article	Year
[The medical management of Cushing's syndrome]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:4 Topics: Adrenal Cortex; Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Combined Modality Therapy; Cushing Syndrome; Dopamine Agonists; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Imidazoles; Mitotane; Pituitary Gland, Anterior; Rosiglitazone; Somatostatin; Thiazolidinediones	2009
Advances in medical therapies for Cushing's syndrome. Discovery medicine, 2012, Volume: 13, Issue:69 Topics: Animals; Bexarotene; Cushing Syndrome; Etomidate; Humans; Ketoconazole; Lapatinib; Metyrapone; Mifepristone; Mitotane; Quinazolines; Somatostatin; Tetrahydronaphthalenes	2012
New prospects for drug treatment in Cushing disease. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:10 Topics: Adenoma; Adrenocorticotropic Hormone; Animals; Cabergoline; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Ergolines; Etomidate; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Metyrapone; Mice; Mifepristone; Mitotane; Multicenter Studies as Topic; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; PPAR gamma; Pyridines; Rats; Somatostatin; Therapies, Investigational; Tretinoin	2012
Medical treatment of Cushing's disease. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:2 Topics: Antineoplastic Agents, Hormonal; Dopamine Agonists; Humans; Mitotane; Octreotide; Pituitary ACTH Hypersecretion; Receptors, Glucocorticoid; Somatostatin	2013
Efficacy of medical treatment in Cushing's disease: a systematic review. Clinical endocrinology, 2014, Volume: 80, Issue:1 Topics: Cabergoline; Ergolines; Female; Humans; Ketoconazole; Male; Metyrapone; Mitotane; Pituitary ACTH Hypersecretion; Somatostatin	2014
Cushing's disease: current medical therapies and molecular insights guiding future therapies. Neurosurgical focus, 2015, Volume: 38, Issue:2 Topics: Clinical Trials as Topic; Drug Delivery Systems; Female; Forecasting; Humans; Male; Mitotane; Pituitary ACTH Hypersecretion; Receptors, Retinoic Acid; Retrospective Studies; Somatostatin	2015
Medical Management of Cushing Disease. Neurosurgery clinics of North America, 2019, Volume: 30, Issue:4 Topics: Cabergoline; Etomidate; Humans; Ketoconazole; Metyrapone; Mitotane; Pituitary ACTH Hypersecretion; Somatostatin; Temozolomide; Treatment Outcome	2019